#62025TO0156Genel Mahkeme (Dördüncü Daire) Kararı, 18 Şubat 2026. Accord Healthcare France SAS ve Dermapharm AG Avrupa Parlamentosu ve Avrupa Birliği Konseyi’ne karşı. İptal davaları – Çevre – Kentsel atık su arıtımı – Direktif (EU) 2024/3019’nin 1, 2, 9, 10 ve 30’uncu maddeleri ile Ek I ve III – İnsan kullanımına yönelik tıbbi ürünler ve kozmetik ürünler için genişletilmiş üretici sorumluluğu – Dava açma ehliyeti – Bireysel etki eksikliği – Kabul edilemezlik. Birleştirilmiş Davalar T-156/25 ve T-157/25.
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
🇬🇧 English
The General Court ruled that Accord Healthcare and Dermapharm could not challenge EU laws on wastewater treatment and producer responsibility for medicines and cosmetics because they were not individually affected. This decision highlights the limitations on who can bring legal actions against EU institutions. The ruling primarily affects companies in the pharmaceutical and cosmetics industries.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Companies cannot challenge EU laws unless they are individually affected.
- Clarification of standing requirements for legal actions against EU institutions.
- Focus on environmental responsibilities for medicinal and cosmetic products.
Affected Parties
Accord HealthcareDermapharm+2 more…
Tags
EU Law,Environmental Regulation,Producer Responsibility…